HDFC Securities has reviewed the Q2 FY27 performance of Infosys, Shriram Finance, SBI Cards, IndusInd Bank, DCB Bank, Torrent Pharma, Dr Reddy's Laboratories, HPCL and Godrej Properties, retaining its ratings while revising target prices for select stocks based on earnings performance, growth prospects and sector-specific challenges.
NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
HDFC Securities Institutional Equities
HDFC Securities has reviewed the Q2 FY27 performance of nine companies, including Infosys, Shriram Finance, SBI Cards, IndusInd Bank, DCB Bank, Torrent Pharmaceuticals, Dr Reddy's Laboratories, Hindustan Petroleum Corporation and Godrej Properties, retaining its existing ratings across all nine stocks while revising target prices for eight.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
In this report, the brokerage maintained Buy ratings on Infosys, DCB Bank, HPCL and Godrej Properties. It retained Add ratings on Shriram Finance and Torrent Pharma, while maintaining Reduce ratings on SBI Cards, IndusInd Bank and Dr Reddy's Laboratories.
ALSO READ | IDFC First Bank Q2 Review: Motilal Oswal Trims Target Price Despite Inline Numbers; Here's Why
The brokerage raised its target price for Shriram Finance to Rs 1,210 from Rs 1,200, SBI Cards to Rs 600 from Rs 595, IndusInd Bank to Rs 815 from Rs 760, DCB Bank to Rs 270 from Rs 245, and Dr Reddy's Laboratories to Rs 1,270 from Rs 1,200.
Meanwhile, it cut its target price for Torrent Pharmaceuticals to Rs 5,000 from Rs 5,270 and HPCL to Rs 415 from Rs 445. The brokerage kept its targets unchanged for Infosys at Rs 1,250 and Godrej Properties at Rs 2,258.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
